SSA
ACIU icon

Schonfeld Strategic Advisors’s AC Immune ACIU Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,400
Closed -$45.5K – 1997
2024
Q2 		$45.5K Buy
+11,400
New +$37.7K ﹤0.01% 1942
2016
Q4 		– Sell
-14,779
Closed -$243K – 530
2016
Q3 		$243K Buy
+14,779
New +$255K 0.04% 336

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Schonfeld Strategic Advisors's ACIU Position: Q3 2024 in Review

Schonfeld Strategic Advisors sold out of AC Immune (ACIU) in Q3 2024, closing a stake of 11,400 shares — an estimated $45.5K sold.

Schonfeld Strategic Advisors first reported a position in ACIU in Q3 2016 and held it in 2 quarters. The position peaked at $243K in Q3 2016. 43 funds tracked by Wall St. Rank hold ACIU as of Q3 2024.

  • Schonfeld Strategic Advisors reported no remaining AC Immune position as of Q3 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 11,400 AC Immune shares in Q3 2024, an estimated $45.5K.
  • Schonfeld Strategic Advisors first reported a position in AC Immune in Q3 2016 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's AC Immune position peaked at $243K in Q3 2016.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.